Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO).
<h4>Background</h4>Excessive haemorrhage at cesarean section requires donor (allogeneic) blood transfusion. Cell salvage may reduce this requirement.<h4>Methods and findings</h4>We conducted a pragmatic randomised controlled trial (at 26 obstetric units; participants recruite...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-12-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1002471 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850160139184635904 |
|---|---|
| author | Khalid S Khan Philip A S Moore Matthew J Wilson Richard Hooper Shubha Allard Ian Wrench Lee Beresford Tracy E Roberts Carol McLoughlin James Geoghegan Jane P Daniels Sue Catling Vicki A Clark Paul Ayuk Stephen Robson Fang Gao-Smith Matthew Hogg Doris Lanz Julie Dodds SALVO study group |
| author_facet | Khalid S Khan Philip A S Moore Matthew J Wilson Richard Hooper Shubha Allard Ian Wrench Lee Beresford Tracy E Roberts Carol McLoughlin James Geoghegan Jane P Daniels Sue Catling Vicki A Clark Paul Ayuk Stephen Robson Fang Gao-Smith Matthew Hogg Doris Lanz Julie Dodds SALVO study group |
| author_sort | Khalid S Khan |
| collection | DOAJ |
| description | <h4>Background</h4>Excessive haemorrhage at cesarean section requires donor (allogeneic) blood transfusion. Cell salvage may reduce this requirement.<h4>Methods and findings</h4>We conducted a pragmatic randomised controlled trial (at 26 obstetric units; participants recruited from 4 June 2013 to 17 April 2016) of routine cell salvage use (intervention) versus current standard of care without routine salvage use (control) in cesarean section among women at risk of haemorrhage. Randomisation was stratified, using random permuted blocks of variable sizes. In an intention-to-treat analysis, we used multivariable models, adjusting for stratification variables and prognostic factors identified a priori, to compare rates of donor blood transfusion (primary outcome) and fetomaternal haemorrhage ≥2 ml in RhD-negative women with RhD-positive babies (a secondary outcome) between groups. Among 3,028 women randomised (2,990 analysed), 95.6% of 1,498 assigned to intervention had cell salvage deployed (50.8% had salvaged blood returned; mean 259.9 ml) versus 3.9% of 1,492 assigned to control. Donor blood transfusion rate was 3.5% in the control group versus 2.5% in the intervention group (adjusted odds ratio [OR] 0.65, 95% confidence interval [CI] 0.42 to 1.01, p = 0.056; adjusted risk difference -1.03, 95% CI -2.13 to 0.06). In a planned subgroup analysis, the transfusion rate was 4.6% in women assigned to control versus 3.0% in the intervention group among emergency cesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 2.2% versus 1.8% among elective cesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interaction p = 0.46). No case of amniotic fluid embolism was observed. The rate of fetomaternal haemorrhage was higher with the intervention (10.5% in the control group versus 25.6% in the intervention group, adjusted OR 5.63, 95% CI 1.43 to 22.14, p = 0.013). We are unable to comment on long-term antibody sensitisation effects.<h4>Conclusions</h4>The overall reduction observed in donor blood transfusion associated with the routine use of cell salvage during cesarean section was not statistically significant.<h4>Trial registration</h4>This trial was prospectively registered on ISRCTN as trial number 66118656 and can be viewed on http://www.isrctn.com/ISRCTN66118656. |
| format | Article |
| id | doaj-art-eb7c8de91fc94996aa032ca73ce2f5df |
| institution | OA Journals |
| issn | 1549-1277 1549-1676 |
| language | English |
| publishDate | 2017-12-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj-art-eb7c8de91fc94996aa032ca73ce2f5df2025-08-20T02:23:15ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762017-12-011412e100247110.1371/journal.pmed.1002471Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO).Khalid S KhanPhilip A S MooreMatthew J WilsonRichard HooperShubha AllardIan WrenchLee BeresfordTracy E RobertsCarol McLoughlinJames GeogheganJane P DanielsSue CatlingVicki A ClarkPaul AyukStephen RobsonFang Gao-SmithMatthew HoggDoris LanzJulie DoddsSALVO study group<h4>Background</h4>Excessive haemorrhage at cesarean section requires donor (allogeneic) blood transfusion. Cell salvage may reduce this requirement.<h4>Methods and findings</h4>We conducted a pragmatic randomised controlled trial (at 26 obstetric units; participants recruited from 4 June 2013 to 17 April 2016) of routine cell salvage use (intervention) versus current standard of care without routine salvage use (control) in cesarean section among women at risk of haemorrhage. Randomisation was stratified, using random permuted blocks of variable sizes. In an intention-to-treat analysis, we used multivariable models, adjusting for stratification variables and prognostic factors identified a priori, to compare rates of donor blood transfusion (primary outcome) and fetomaternal haemorrhage ≥2 ml in RhD-negative women with RhD-positive babies (a secondary outcome) between groups. Among 3,028 women randomised (2,990 analysed), 95.6% of 1,498 assigned to intervention had cell salvage deployed (50.8% had salvaged blood returned; mean 259.9 ml) versus 3.9% of 1,492 assigned to control. Donor blood transfusion rate was 3.5% in the control group versus 2.5% in the intervention group (adjusted odds ratio [OR] 0.65, 95% confidence interval [CI] 0.42 to 1.01, p = 0.056; adjusted risk difference -1.03, 95% CI -2.13 to 0.06). In a planned subgroup analysis, the transfusion rate was 4.6% in women assigned to control versus 3.0% in the intervention group among emergency cesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 2.2% versus 1.8% among elective cesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interaction p = 0.46). No case of amniotic fluid embolism was observed. The rate of fetomaternal haemorrhage was higher with the intervention (10.5% in the control group versus 25.6% in the intervention group, adjusted OR 5.63, 95% CI 1.43 to 22.14, p = 0.013). We are unable to comment on long-term antibody sensitisation effects.<h4>Conclusions</h4>The overall reduction observed in donor blood transfusion associated with the routine use of cell salvage during cesarean section was not statistically significant.<h4>Trial registration</h4>This trial was prospectively registered on ISRCTN as trial number 66118656 and can be viewed on http://www.isrctn.com/ISRCTN66118656.https://doi.org/10.1371/journal.pmed.1002471 |
| spellingShingle | Khalid S Khan Philip A S Moore Matthew J Wilson Richard Hooper Shubha Allard Ian Wrench Lee Beresford Tracy E Roberts Carol McLoughlin James Geoghegan Jane P Daniels Sue Catling Vicki A Clark Paul Ayuk Stephen Robson Fang Gao-Smith Matthew Hogg Doris Lanz Julie Dodds SALVO study group Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). PLoS Medicine |
| title | Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). |
| title_full | Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). |
| title_fullStr | Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). |
| title_full_unstemmed | Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). |
| title_short | Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). |
| title_sort | cell salvage and donor blood transfusion during cesarean section a pragmatic multicentre randomised controlled trial salvo |
| url | https://doi.org/10.1371/journal.pmed.1002471 |
| work_keys_str_mv | AT khalidskhan cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT philipasmoore cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT matthewjwilson cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT richardhooper cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT shubhaallard cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT ianwrench cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT leeberesford cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT tracyeroberts cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT carolmcloughlin cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT jamesgeoghegan cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT janepdaniels cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT suecatling cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT vickiaclark cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT paulayuk cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT stephenrobson cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT fanggaosmith cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT matthewhogg cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT dorislanz cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT juliedodds cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo AT salvostudygroup cellsalvageanddonorbloodtransfusionduringcesareansectionapragmaticmulticentrerandomisedcontrolledtrialsalvo |